-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US8887051006 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | 2M |
|---|---|
| PE Ratio | None |
| Target Price | 210 |
| Beta | 1.98 |
| Dividend Yield | None |
Tivic Health Systems, Inc., a health tech company, develops and commercializes bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for use in the treatment of sinus pain, pressure, and congestion. The company sells its products through online retailers and commercial distributors, as well as its own website. Its lead product candidate is Entolimod, a late-stage TLR5 agonist for use in the treatment of acute radiation syndrome. In addition, the company markets its commercial product under the ClearUP Sinus Pain Relief brand name. It also focusses on non-invasive vagus nerve stimulation. The company was incorporated in 2016 and is based in Fremont, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for TIVC using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026